Healthcare & Life Sciences
GenEdit
United Statesgenedit.com
GenEdit is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About GenEdit
GenEdit is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
GenEdit develops non-immunogenic nanoparticle delivery technologies to enable precise and safe transport of genetic medicines, including CRISPR-based therapies, to target cells for treating autoimmune diseases and other conditions.
Explore GenEdit's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.